Clinical Trial Detail

NCT ID NCT02576574
Title Avelumab in First-line Non-Small Cell Lung Cancer (JAVELIN Lung 100)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements yes
Sponsors EMD Serono
Indications

non-small cell lung carcinoma

Therapies

Gemcitabine

Paclitaxel

Cisplatin

Avelumab

Pemetrexed

Carboplatin

Age Groups: adult

Additional content available in CKB BOOST